Monografie
Development of bispecific antibodies with optimized T cell costimulatory activity
- Sprache
-
Englisch
- Identifier
-
1271678934
- Thema
-
Antikörper; Immunreaktion; Immunsystem; Monoklonaler bispezifischer Antikörper; B-Lymphozyt; Immuntherapie; Antikörper ; Immunologie ; Immunbiologie ; Tumorimmunologie ; Immuntherapie ; Proteindesign
- Beteiligte Personen und Organisationen
-
Manz, Timo
Jung, Gundram
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
28.02.2023, 11:39 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Monografie
Beteiligte
- Manz, Timo
- Jung, Gundram
Ähnliche Objekte (12)
Optimized One-Click Development for Topology-Optimized Structures
Clinical development of antibodies
Intracellular antibodies : development and applications
Development of conformation specific Amyloid-beta antibodies
Fc-optimized antibodies for the treatment of B-cell acute lymphoblastic leukemia and colorectal cancer
Electrochemical Activity and Electrical Properties of Optimized Polypyrrole Coatings on Iron
An Optimized Micromethod for Determining the Catalytic Activity of Serum Ribonuclease
Interrogating PP1 activity in the MAPK pathway with optimized PP1‐disrupting peptides
Monoclonal antibodies
Therapeutic antibodies
Anti-Bodies
Recombinant antibodies
Optimized One-Click Development for Topology-Optimized Structures
Clinical development of antibodies
Intracellular antibodies : development and applications
Development of conformation specific Amyloid-beta antibodies
Fc-optimized antibodies for the treatment of B-cell acute lymphoblastic leukemia and colorectal cancer
Electrochemical Activity and Electrical Properties of Optimized Polypyrrole Coatings on Iron
An Optimized Micromethod for Determining the Catalytic Activity of Serum Ribonuclease
Interrogating PP1 activity in the MAPK pathway with optimized PP1‐disrupting peptides
Monoclonal antibodies
Therapeutic antibodies
Anti-Bodies
Recombinant antibodies
Optimized One-Click Development for Topology-Optimized Structures
Clinical development of antibodies
Intracellular antibodies : development and applications
Development of conformation specific Amyloid-beta antibodies
Fc-optimized antibodies for the treatment of B-cell acute lymphoblastic leukemia and colorectal cancer
Electrochemical Activity and Electrical Properties of Optimized Polypyrrole Coatings on Iron
An Optimized Micromethod for Determining the Catalytic Activity of Serum Ribonuclease
Interrogating PP1 activity in the MAPK pathway with optimized PP1‐disrupting peptides
Monoclonal antibodies
Therapeutic antibodies
Anti-Bodies